Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 61–90 of 577 companies · sorted by market cap (high to low)
254 covered companies have no sector on record (3IN.L, AAF.L, AAL.L, ABDN.L, ABF.L, ADM.L, AEP.L, AJB.L, ALFA.L, AML.L, ANTO.L, AO.L), so they were not tested by this filter — a gap in our sector data, not evidence they do not belong here.
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| VTRS | Viatris | Health Care | $16.88 | $19.4B | n/a | +4.4% | -24.6% | +2.7% | +63.4% |
| ZBH | Zimmer Biomet | Health Care | $98.07 | $18.7B | 23.9 | +8.6% | +8.6% | +1.0% | -6.4% |
| MEDP | Medpace | Health Care | $591.29 | $16.5B | 34.7 | +24.7% | +17.8% | n/a | +22.6% |
| JAZZ | Jazz Pharmaceuticals | Health Care | $246.81 | $16.0B | 16.9 | +12.6% | -8.3% | n/a | +92.8% |
| NBIX | Neurocrine Biosciences | Health Care | $155.64 | $15.8B | 22.8 | +34.4% | +16.7% | n/a | +10.9% |
| SOLV | Solventum | Health Care | $91.69 | $15.6B | 11.2 | -0.9% | +18.7% | n/a | +26.7% |
| BBIO | BridgeBio Pharma, Inc. | Health Care | $74.84 | $14.6B | n/a | +355.2% | -146.0% | n/a | +44.4% |
| EXEL | Exelixis | Health Care | $59.01 | $14.6B | 18.5 | +9.2% | +33.7% | n/a | +57.9% |
| RVTY | Revvity | Health Care | $130.22 | $14.5B | 62.0 | +4.0% | +8.4% | +0.3% | +51.9% |
| SMMT | Summit Therapeutics | Health Care | $17.61 | $14.0B | n/a | n/a | n/a | n/a | -26.0% |
| CRL | Charles River Laboratories | Health Care | $288.50 | $13.8B | n/a | -0.7% | -3.6% | n/a | +77.7% |
| COO | Cooper Companies (The) | Health Care | $69.59 | $13.6B | 58.8 | +6.1% | +9.2% | +0.0% | +2.3% |
| BAX | Baxter International | Health Care | $25.83 | $13.4B | n/a | +5.4% | -8.5% | +3.2% | +9.5% |
| BMRN | BioMarin Pharmaceutical | Health Care | $66.53 | $12.9B | 183.9 | +11.2% | +10.8% | n/a | +17.2% |
| PEN | Penumbra, Inc. | Health Care | $322.17 | $12.7B | 79.1 | +17.6% | +12.7% | n/a | +15.2% |
| HALO | Halozyme | Health Care | $110.19 | $12.5B | 32.9 | +41.1% | +22.7% | n/a | +50.1% |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Health Care | $541.08 | $12.5B | n/a | +149.0% | -30.1% | n/a | +25.5% |
| ELAN | Elanco | Health Care | $24.50 | $12.2B | n/a | +11.9% | -4.9% | n/a | +40.2% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Health Care | $86.34 | $12.2B | n/a | +16.9% | -0.2% | n/a | +208.4% |
| CORT | Corcept Therapeutics | Health Care | $111.62 | $12.1B | 262.0 | +16.0% | +13.1% | n/a | +60.9% |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | Health Care | $60.73 | $12.0B | 36.7 | +19.9% | +1.5% | n/a | +152.1% |
| EHC | Encompass Health | Health Care | $121.79 | $12.0B | 20.3 | +10.1% | +9.5% | +0.9% | -2.2% |
| DVA | DaVita | Health Care | $183.99 | $11.7B | 15.1 | +6.5% | +5.5% | n/a | +35.7% |
| TECH | Bio-Techne | Health Care | $72.43 | $11.4B | 105.0 | +0.2% | +6.0% | +0.5% | +36.9% |
| ALGN | Align Technology | Health Care | $158.64 | $11.3B | 27.5 | +4.4% | +10.2% | n/a | +17.8% |
| AXSM | Axsome Therapeutics, Inc. | Health Care | $206.68 | $10.8B | n/a | +56.9% | -28.7% | n/a | +66.1% |
| BIO | Bio-Rad Laboratories | Health Care | $386.11 | $10.7B | 46.8 | +1.4% | +29.4% | n/a | +33.4% |
| KRYS | KRYSTAL BIOTECH INC | Health Care | $358.24 | $10.6B | 44.9 | +22.6% | +52.6% | n/a | +139.2% |
| GMED | Globus Medical | Health Care | $78.29 | $10.5B | 20.0 | +19.7% | +18.3% | n/a | +29.9% |
| MOH | Molina Healthcare | Health Care | $200.80 | $10.5B | n/a | +2.5% | +1.0% | n/a | +17.5% |
Every view here has its own address — copy the link from your browser to share exactly what you are looking at. Click a column header to sort.
Data: SEC EDGAR (filings) + market data (prices, fundamentals). Prices on this page are from the 2026-09-04 close or later — each figure is labelled with its own as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date. Past performance does not indicate future results.